Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination

MLA

Georgiana Cabău, et al. “Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 MRNA Vaccination.” Vaccines, vol. 12, no. 7, July 2024, p. 736. EBSCOhost, https://doi.org/10.3390/vaccines12070736.

APA

Georgiana Cabău, Medeea Badii, Andreea M. Mirea, Orsolya I. Gaal, Liesbeth van Emst, Radu A. Popp, Tania O. Crișan, & Leo A. B. Joosten. (2024). Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination. Vaccines, 12(7), 736. https://doi.org/10.3390/vaccines12070736

Chicago

Georgiana Cabău, Medeea Badii, Andreea M. Mirea, Orsolya I. Gaal, Liesbeth van Emst, Radu A. Popp, Tania O. Crișan, and Leo A. B. Joosten. 2024. “Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 MRNA Vaccination.” Vaccines 12 (7): 736. doi:10.3390/vaccines12070736.